DREAMERS: Does Perioperative Music Prevent Sleep Disturbances in Hospitalized Surgical Patients

Sponsor
Erasmus Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT06131034
Collaborator
(none)
126
1
2
8.7
14.4

Study Details

Study Description

Brief Summary

Sleep disturbances are known to be a prevalent problem in hospitalized, surgical patients, which is of importance since sleep disturbances can lead to a range of negative health outcomes. Music interventions have shown potential in improving sleep quality. Unfortunately, the studies on the effect of music on sleep in surgical patient populations are still scarce and of low quality. Therefore, the aim of this study is to study the effect of music on sleep quality in oncological, gastro-intestinal surgical patients in the form of a randomized controlled trial. Participants will be divided in 2 groups, a music group and a control group, where the music group will receive music interventions perioperatively. The researchers will compare both groups to see if there is a difference in sleep quality.

Condition or Disease Intervention/Treatment Phase
  • Other: Music
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
126 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Does Perioperative Music Prevent Sleep Disturbances in Hospitalized Surgical Patients
Actual Study Start Date :
Aug 9, 2023
Anticipated Primary Completion Date :
Mar 1, 2024
Anticipated Study Completion Date :
May 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Music group

Other: Music
Participant in the intervention group will receive music interventions perioperatively.

No Intervention: Control group

Outcome Measures

Primary Outcome Measures

  1. Subjective sleep quality assessed using a questionnaire [On the morning of day 2, 3 and 4 at the surgical ward]

    Using the Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep disturbance questionnaire, raw summary score

Secondary Outcome Measures

  1. Subjective sleep quantity [During the (possible) intervention period, until day 5 postoperatively]

    Using the adapted Consensus Sleeping Diary

  2. Objective sleep assessment [During the (possible) intervention period, until day 5 postoperatively]

    Measured with an actigraphy device

  3. Music listening during study period [During the (possible) intervention period, until day 5 postoperatively]

    Using a diary

  4. Anxiety [Every morning during the (possible) intervention period, until day 5 postoperatively]

    Using the The State-Trait Anxiety Inventory-6 (STAI-6), 20-80, with a high score being a worse outcome

  5. Subclinical stess using [At baseline and at the end of the (possible) intervention period, at day 5 postoperatively]

    Using the Subclinical Stress Symptoms Questionnaire (SSQ-25).

  6. Postoperative quality of recovery using a questionnaire [At baseline, at the end of the (possible) intervention period (from start of study until day 5 postoperatively) and 30 days after discharge]

    Quality of Recovery-40 score (QOR-40)

  7. Patient satisfaction using a self-made questionnaire [At the end of the study period, 30 days after discharge]

    A Likert scale will be used, 0 -10, with a higher score meaning a more satisfied feeling regarding the hospital admittance.

  8. Music preference and importance in daily life [At baseline]

    Using a questionnaire with use of multiple chose questions and a Likert scale, 0 - 10, with a higher score resulting in a more positive attitude towards music

  9. Cost consequences and cost-effectiveness [30 days after discharge]

    Using the Institute for Medical Technology Assessment (iMTA) medical consumption questionnaire and the iMTA productivity loss questionnaire

  10. Cost consequences and cost-effectiveness [30 days after discharge]

    Using the Institute for Medical Technology Assessment (iMTA) productivity loss questionnaire

  11. Quality of life score [At baseline, at the end of the (possible) intervention period (from start of study until day 5 postoperatively) and 30 days after discharge]

    Using the EuroQol-5dimension-5length (EQ-5D-5L), with a score of 0 - 100, where a higher score

  12. Delirium incidence [During the entire hospital stay surrounding the surgery, up to day 30 postoperatively.]

    Delirium Observation Scale per day and delirium diagnosis (defined as diagnosis by clinician)

Other Outcome Measures

  1. Area of residence [At baseline]

    Using postal code of current address

  2. General medication use (incidence and concentration) [Before and during admittance, retrospectively, with a maximum of day 30 postoperatively]

    Medication use that could be of influence on sleep quality

  3. Physical parameter, bloodpressure [During the entire hospital stay surrounding the surgery, up to day 30 postoperatively.]

    in mm/Hg

  4. Physical parameter, pulse rate [During the entire hospital stay surrounding the surgery, up to day 30 postoperatively.]

    beats/min

  5. Physical parameter, respiratory rate [During the entire hospital stay surrounding the surgery, up to day 30 postoperatively.]

    Resp/min

  6. Perioperative complications [During the entire hospital stay surrounding the surgery, up to day 30 postoperatively.]

    Number of patients with medical complications, and grading of these complications using Clavien Dindo and the Comprehensive Complication Index (CCI)

  7. Clinical information checklist [During the entire hospital stay surrounding the surgery, up to day 30 postoperatively.]

    Information about type of surgery, selected medical history, age, gender, hospital length of stay

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients aged 18 years or older

  • Patients undergoing major elective abdominal surgery for malignant disease, including, but not limited to: Esophageal, gastric, colorectal, hepatic, pancreatic, gynecological and urological surgical procedures.

  • Sufficient knowledge of the Dutch language.

  • Communicable and able to assess the questionnaires

  • Written informed consent acquired from the patient.

Exclusion Criteria:
  • Patients with severe hearing impairment (defined as no or barely verbal communication possible).

  • The patient is expected to be transferred to another hospital postoperatively.

  • Participation in another study that may possibly intervene with the outcome measures. (e.g. in trial use of sleep medication, interventions regarding sleep quality or quantity or similar procedures)

  • Assessment of primary outcome is not possible.

  • Inability or unwillingness to receive the music intervention.

  • Inability to wear the actigraphy device, or inability to perform actigraphy measurement due to paralysis.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Erasmus Medical Center Rotterdam Zuid-Holland Netherlands 3015 CN

Sponsors and Collaborators

  • Erasmus Medical Center

Investigators

  • Principal Investigator: C. Verhoef, Professor, Erasmus Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
C. Verhoef, Prof. Dr. C. Verhoef, Erasmus Medical Center
ClinicalTrials.gov Identifier:
NCT06131034
Other Study ID Numbers:
  • NL78543.078.21
First Posted:
Nov 14, 2023
Last Update Posted:
Nov 14, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 14, 2023